Top Markets
Coin of the day
Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH
Rank in Stocks #42276
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$2.62K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Anthera Pharmaceuticals, Inc. (ANTH)

Category

Stock price history for Anthera Pharmaceuticals, Inc. (ANTH)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $450.76 on 2010-03-01
Stock price history of Anthera Pharmaceuticals, Inc. from 2010 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 -18.71%
2024 -4.67%
2023 0.00%
2022 -15.38%
2021 -99.38%
2020 -48.36%
2019 -0.60%
2018 -97.65%
2017 -88.08%
2016 -65.41%
2015 166.78%
2014 -38.48%
2013 -45.84%
2012 -89.34%
2011 26.69%
2010 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -6.86%
KR